Phree... if you're going to rag on Armed or anyone else... at least learn to spell so that you don't look stupid in the process of trying to accomplish something.
Here's the deal... with so little volume on a day to day basis in ONCY... it's very easy to manipulate the stock. Those that want to buy alot of shares at a lower price... just to have to sell a FEW shares now... in order to buy ALOT of shares later at that lower price. Pretty simple. But if you already own shares... kind of stupid to follow the herd and sell. Time to just go fishing and come back in 6 months. If you watch this every day... it's going to give you grey hair or no hair. Enjoy.
It certainly appears that the news coming out of ONCY is much further along... i.e. Phase III vs Phase II for CYCC and oncy already has their SPA. What CYCC has is a New Jersey based company with a good PR team. Oncy is behind the curve on the PR side... but have great technology... which will eventually prove itself out with the share price. Hang on in there.
Venture... until a company actually starts commercializing a venture and starts making a profit... it's NOT a "stock"... it's an "opportunity" and a "story". In the case of Oncolytics Biotech... the "story" appears to be a good one. But as with any biotech that must go thru clinical trials... the story is not a FAST one. So if you are looking for fast and an immediate return... ONCY the company or the stock is not for you. Hence I would suggest you sell and others will likely buy your stock. The company and investors need two things... patients (for more clinical trials) and patience... because this is not a fast process. Tough decision... if I recall correctly you're in your 60's and it sure would be nice to have a nice triple or home run so that you can go off and play and enjoy your years before you get too old. Hell... I'm pushing 50 and I certainly want to do the same thing. I too would like to have a nice triple or double so I can go off and play a bit more. But if you're looking for a killing and or quicker return and you have a fair appetite for risk... I'd say just go to Vegas and throw a bunch of money on red at the roulette table and see what happens. I'd say the chances with Oncy are really going to be very similar to that spin at the roulette wheel. But at least with roulette... you'll probably find your answer MUCH sooner. Personally I believe Oncy is worth the wait... even if it takes another couple of years to get there. The reality is that the fight on Cancer has been going for at least 40 years. Another year or so is a drop in the bucket in that span of time. For more perspective on that take a look at this article from the NY Times http://www.nytimes.com/2009/12/29/health/research/29cancer.html?scp=4&sq=cancer&st=cse Good luck and happy new year.
Wow... what a serious shorting agenda you have. The fact remains is... is that any company attempting to get something going in this space is going to have to have great technology and the patience to go through the years of clinical trials to make it happen. I'm bullish and optimistic based upon the FDA's opinion on the last Phase III. That speaks volumes. Do they have a ways to go? Yes. But making all the right moves now. And your previous diatribe only further speaks to your financial agenda... rather than just speaking facts. At the end of the day it's just a waiting game. So go in your corner and sit in time out... and we'll all find out soon enough.
Regardless... the company appears to have done what they needed to do to get their funding to bring them to this point and beyond. It's been a long road and many othe comapanies would have failed in the attempt a long time a go. But they have survived and looks like they have pretty damn close to proving their model. If ONCY does what it has already proven for the most part... than their value will exceed a Billion and then some... ultimately making the $$$ amounts you are talking about now seem very trivial. IMHO.
Hiring this person is a very bullish sign for the company. No company (big or small) invests money in more business development people until they believe they have a viable product to sell. Additionally what this also shows that ONCY is doing the right things to bring the product to market themselves... without waiting for some big pharma company to scoop them up. In so doing... the longer that ONCY is able to drive the sales machine themselves... the more they can also drive the sales price higher... prior to any other company attempting to buy them. It's a very positive sign. Enjoy the ride.
Armed... I sent you a note about a week ago... with 3 pics of my daughter. Did you not get that? If not... send me a another note to those old email addresses. I will get one and send another return note to you.
This article appeared in today's NY Times. Take it for what it's worth and determine for yourself how ONCY compares. http://www.nytimes.com/2009/12/05/health/05drug.html?_r=1&?8dpc
Armed... you remember. Very good. I hope you and your wife are well. If you still have my email address lying around... send me a note and I will send you pics of my daughter who's now 3 and half. And THAT's what's really important. I've accumulated a relatively small (compared to yours) position back in Oncy... after losing a bit of my shirt on another pharmaceutical company a couple of years ago. But all that is a story for another day. In any event... great hearing from you. All the best... Michael
For what it's worth... I agree with the original posting. I often come to the board looking for any new information that will make me feel more or less comfortable with my investment... only to find that this board appears to be a political forum instead of a stock or science forum. So while I appreciate everyone's passion for these political issues... it seems that there are many places on the internet that one can go to discuss, rant and rave about those subjects. To the point... let's stay on point. I know though it's tough... someone out there baits people with a sensitive subject and it's ever so tempting to respond. But those folks are probably best ignored because it ultimately makes having this stock message board a worthless medium when there is little or no information to be found here regarding the actual company. Just my humble opinion.
Alex... don't count the chickens too soon before they hatch! Nothing hexes a deal faster than talking about all the cash... before the cows actually get back to the barn. Your old friend Michael from Denver.
I found it interesting in Gild's press release on May 21st... the guy who is charge of research for Gild seemed to leave open the door... that maybe it makes sense that Ambri is not approved this time around and that more clinical trials are needed when he said...
"PAH is a chronic disease and, as such, we recognize the importance of evaluating the long-term efficacy and safety profile of ambrisentan," said Michael J. Gerber, MD, Senior Vice President, Clinical Research at Gilead. "We will continue to work with the clinical investigators and follow patients from each of these studies so we can better understand the benefits and risks of ambrisentan with long-term treatment."
Here's the deal... GILD is a great company that's currently valued at $32 BILLION dollars. It actually might NOT be in Gild's best interest to have ambri approved... go to market... and then wind up significantly damaging gild's reputation by having a product go to market that is not everything that they hoped it would be.
So hence in my strange world... I actually think that GILD is going to ask that the FDA give ambri an "approvable" as opposed to approved... just to protect the integrity of the rest of their company and their stock price.
I welcome your thoughts.
Patience my man. This is not a day trade stock. One of the major things on the horizon is the work Palatin in doing with female sexual dysfunction. There's really nothing in that space. My wife is an OB gyn and is very much looking forward to the day when she can give some type of drug to her patients for sexual dysfunctional or low arousal in women. Patience. This is one company I don't worry about.
I thought the most troubling part of the conference call from a shareholders standpoint... was their comments having to do with reverse splits. They basically sidestepped the question by saying that they would ultimately do "what's best for the company"... Which basically means... what's good for the company isn't really good for the average joe stockholder holding at these levels. If you are thinking that you are going to get rich by holding 500,000 shares at this level... you are definitely going to be in for a rude awakening come reverse split time.
You know... you're a moron. You wrap yourself in this veil of attempting to do other people a favor. But you're nothing more than a heinous piece of pond scum that's trying to make a buck in a way that nobody here respects. For you, you believe the end justifies the means... and you believe the end means making a few more dollars. But in the REAL END... there's just going to be a tombstone that reads... here lies a man that added ZERO value to this world. Get a life and please don't infect the gene pool by procreating anytime soon.